Literature DB >> 10202650

Psychiatric comorbidity of eating disorders in men: a national study of hospitalized veterans.

R H Striegel-Moore1, V Garvin, F A Dohm, R A Rosenheck.   

Abstract

OBJECTIVE: This study examined eating disorders and their psychiatric comorbidity in a national sample of hospitalized male veterans.
METHOD: Review of discharge summaries for 466,590 male patients from Veterans Affairs medical centers for fiscal year 1996 resulted in the identification of 98 men with a current ICD-9-CM diagnosis of an eating disorder. For the comorbidity analyses, eating disorder cases were matched with controls drawn randomly from the pool of male patients without an eating disorder, using age and race as matching variables.
RESULTS: There was a high rate of comorbid substance use and mood disorder for men with anorexia nervosa (AN), bulimia nervosa (BN), and eating disorder not otherwise specified (EDNOS). Men with AN were also at high risk for comorbid schizophrenia/psychotic disorder, men with BN were at risk for comorbid personality disorder, and men with EDNOS were at special risk for comorbid organic mental disorder and schizophrenia/psychotic disorder. DISCUSSION: For each eating disorder, there was a distinct pattern of psychiatric comorbidity that deserves further study.

Entities:  

Mesh:

Year:  1999        PMID: 10202650     DOI: 10.1002/(sici)1098-108x(199905)25:4<399::aid-eat4>3.0.co;2-0

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  17 in total

Review 1.  The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods.

Authors:  Chiao-Wen Lan; David A Fiellin; Declan T Barry; Kendall J Bryant; Adam J Gordon; E Jennifer Edelman; Julie R Gaither; Stephen A Maisto; Brandon D L Marshall
Journal:  Am J Addict       Date:  2015-12-22

2.  Differential Risk Factors for Unhealthy Weight Control Behaviors by Sex and Weight Status Among U.S. Adolescents.

Authors:  Jason M Nagata; Andrea K Garber; Jennifer L Tabler; Stuart B Murray; Kirsten Bibbins-Domingo
Journal:  J Adolesc Health       Date:  2018-09       Impact factor: 5.012

3.  Comorbidity and age of onset of eating disorders in gay men, lesbians, and bisexuals.

Authors:  Matthew B Feldman; Ilan H Meyer
Journal:  Psychiatry Res       Date:  2010-05-21       Impact factor: 3.222

4.  Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders.

Authors:  S Gebhardt; M Haberhausen; J-C Krieg; H Remschmidt; M Heinzel-Gutenbrunner; J Hebebrand; F M Theisen
Journal:  J Neural Transm (Vienna)       Date:  2007-03-20       Impact factor: 3.575

5.  Eating disorders in men: current features and childhood factors.

Authors:  B Mangweth-Matzek; C I Rupp; A Hausmann; S Gusmerotti; G Kemmler; W Biebl
Journal:  Eat Weight Disord       Date:  2010 Mar-Jun       Impact factor: 4.652

6.  Identifying Individuals with Eating Disorders Using Health Administrative Data.

Authors:  Paul Kurdyak; Claire de Oliveira; Tomi Iwajomo; Susan Bondy; Kathryn Trottier; Patricia Colton
Journal:  Can J Psychiatry       Date:  2019-05-02       Impact factor: 4.356

Review 7.  Eating disorders and schizophrenia in male patients: a review.

Authors:  R Bou Khalil; D Hachem; S Richa
Journal:  Eat Weight Disord       Date:  2011-09       Impact factor: 4.652

Review 8.  Eating disorders and psychosis: Seven hypotheses.

Authors:  Mary V Seeman
Journal:  World J Psychiatry       Date:  2014-12-22

9.  Eating disorder symptoms and comorbid psychopathology among male and female veterans.

Authors:  Scott D Litwack; Karen S Mitchell; Denise M Sloan; Annemarie F Reardon; Mark W Miller
Journal:  Gen Hosp Psychiatry       Date:  2014-04-01       Impact factor: 3.238

Review 10.  The relationship between eating disorder not otherwise specified (EDNOS) and officially recognized eating disorders: meta-analysis and implications for DSM.

Authors:  Jennifer J Thomas; Lenny R Vartanian; Kelly D Brownell
Journal:  Psychol Bull       Date:  2009-05       Impact factor: 17.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.